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Summary
Lipid metabolism in Trypanosoma brucei, the causa-
tive agent of African sleeping sickness, differs from its
human host in several fundamental ways. This has
lead to the validation of a plethora of novel drug
targets, giving hope of novel chemical intervention
against this neglected disease. Cytidine diphosphate
diacylglycerol (CDP-DAG) is a central lipid intermedi-
ate for several pathways in both prokaryotes and
eukaryotes, being produced by CDP-DAG synthase
(CDS). However, nothing is known about the single
T. brucei CDS gene (Tb927.7.220/EC 2.7.7.41) or its
activity. In this study we show TbCDS is functional by
complementation of a non-viable yeast CDS null strain
and that it is essential in the bloodstream form of the
parasite via a conditional knockout. The TbCDS con-
ditional knockout showed morphological changes
including a cell-cycle arrest due in part to kinetoplast
segregation defects. Biochemical phenotyping of
TbCDS conditional knockout showed drastically
altered lipid metabolism where reducing levels of
phosphatidylinositol detrimentally impacted on gly-
coylphosphatidylinositol biosynthesis. These studies
also suggest that phosphatidylglycerol synthesized
via the phosphatidylglycerol-phosphate synthase is
not synthesized from CDP-DAG, as was previously
thought. TbCDS was shown to localized the ER and
Golgi, probably to provide CDP-DAG for the phos-
phatidylinositol synthases.
Introduction
Trypanosoma brucei, the causative agent of African sleep-
ing sickness, expresses a variant surface glycoprotein
(VSG) coat, which protects the parasite from the alterna-
tive complement pathway and from a specific immune
response by antigenic variation (Cross, 1996). The 5 × 106
VSG dimers are held in the outer leaflet plasma membrane
of the parasite by glycosylphosphatidylinositol (GPI)
anchors. The biosynthesis of this conserved GPI anchor
has been previously genetically (Nagamune et al., 2000;
Chang et al., 2002) and chemically validated (Smith et al.,
2004) as a drug target in bloodstream form T. brucei. The
importance of GPI anchors to T. brucei has lead our group
to investigate various aspects of lipid metabolism, some
enzymes of which have already been shown to be essen-
tial (reviewed in Smith and Buetikofer, 2010). The nucle-
olipid cytidine diphosphate diacylglycerol (CDP-DAG) is
a key metabolite, acting as a high energy donor in the
synthesis of numerous phospholipids in both prokaryotes
and eukaryotes. In T. brucei these include synthesis of
phosphatidylinositol (PI), which is essential for the produc-
tion of GPI anchors (Martin and Smith, 2006b), and
potentially phosphatidyglycerol (PG), cardolipin (CL) and
phosphatidylserine (PS). CDP-DAG is synthesized by the
enzyme CDP-DAG synthase (CDS) (EC 2.7.7.41) from
cytidine triphosphate (CTP) and phosphatidic acid (PA)
(Fig. 1A).
A gene encoding CDS activity was first discovered in
E. coli mutants deficient in CDP-DAG synthesis (Ganong
et al., 1980; Ganong and Raetz, 1982). In Drosophila a
photoreceptor CDS is involved in phosphoinositide signal-
ling and vision (Wu et al., 1995), which increased interest in
the gene and led to its cloning and study in yeast (Shen
et al., 1996) and a variety of mammals (Heacock et al.,
1996; Saito et al., 1997; Halford et al., 1998; Volta et al.,
1999; Inglis-Broadgate et al., 2005). CDS homologues
have now been identified in all eukaryotic genomes
sequenced to date and some organisms have multiple
CDS genes (Lykidis, 2007). The genes show high
sequence similarity, suggesting a degree of conservation
during evolution. All identified CDS enzymes are integral
membrane proteins. In prokaryotes, CDS activity is asso-
ciated with the inner membrane of the cell envelope (Bell
et al., 1971; White et al., 1971) and in eukaryotes the
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majority of activity has been found in the ER and mitochon-
dria (Bishop and Strickland, 1976; Kuchler et al., 1986;
Kelley and Carman, 1987; Mok et al., 1992; Heacock and
Agranoff, 1997).
The fact that the pool of CDP-DAG is much smaller
than that of CDS’s lipid substrate PA (Raetz and
Kennedy, 1973; Thompson and MacDonald, 1975;
Nickels et al., 1994) along with the position of CDS at a
branch point in phospholipid synthesis suggests CDP-
DAG synthesis may be a rate-limiting step. In yeast, CDS
is under tight transcriptional regulation via the inositol-
responsive cis-acting element and trans-acting factors
(reviewed in Carman and Han, 2011), but in other organ-
isms regulation varies greatly (Carter and Kennedy, 1966;
Sribney et al., 1977; Langley and Kennedy, 1978;
Ganong and Raetz, 1982; Baelee and Carman, 1984;
Icho et al., 1985; Kelley and Carman, 1987; Carman and
Baelee, 1992; Mok et al., 1992; Shen and Dowhan, 1996;
Lykidis et al., 1997; Saito et al., 1997; Sato et al., 2000;
Haselier et al., 2010).
CDS null mutants in yeast (Shen and Dowhan, 1996;
Shen et al., 1996), E. coli (Ganong and Raetz, 1982)
and Synechocystis (Sato et al., 2000) are inviable due to
massive direct and indirect disruption of phospholipid
synthesis. Due to the essential requirement for PI
(Martin and Smith, 2006a,b), phosphorylated PIs (PIPs)
(Rodgers et al., 2007) and GPI anchors (Nagamune
et al., 2000; Chang et al., 2002; Smith et al., 2004) in
T. brucei, it seemed likely that CDS would be essential
for the parasite, therefore presenting a possible novel
drug target. In order to validate CDS as a drug target we
created a conditional knockout in the bloodstream form
parasite, which has highlighted several novel aspects of
phospholipid metabolism in this early divergent eukary-
otic parasite.
Results
Cloning and sequencing T. brucei CDS (TbCDS)
A putative CDS was identified in the T. brucei genome
database (Sanger Centre) using Blast (Tb927.2.220). This
putative ORF was PCR amplified, cloned and sequenced.
The sequence and its translation are shown in Fig. S1. An
alignment of the predicted translated sequence with CDSs
from other organisms is shown in Fig. S2A, with a corre-
sponding phylogenetic tree in Fig. S2B. Unsurprisingly,
TbCDS is closely related to other kinetoplastids, showing
S
M
S
M
D
M
D
M
M
W
Origin
Posi?on of 
CDP-DAG 
Standard
Front
FORMATION OF 
[3H]CDP-DAG
A
B
Fig. 1. CDP-DAG synthase activity.
A. Schematic of the enzymatic reaction
catalysed by CDP-DAG synthase.
B. TbCDS assay of T. brucei lysate,
autoradiography of a representative
HPTLC of lipid fraction shows
[3H]CDP-DAG formation from [3H]CTP and
PA. The position of unlabelled CDP-DAG
standard run in the same solvent system
and visualized by iodine is indicated on the
right hand side.
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99% identity with the T. b. brucei strain 927 and T. b. gam-
biense; 64% with T. cruzi, 60% with T. vivax and 49–50%
with various Leishmania species, while significantly less to
the two human CDS homologues. The size of the predicted
TbCDS protein is 46 kDa, which is in good agreement with
other eukaryotic CDSs such as Arabidopsis thaliana CDS5
at 39.9 kDa (Haselier et al., 2010) and the human CDS1 at
46.1 kDa (Heacock et al., 1996).
TbCDS is highly hydrophobic with a grand average
of hydropathicity of 0.285 (Kyte and Doolittle, 1982) with
7 predicted transmembrane domains (highlighted in
Fig. S1). This is consistent with all identified CDS enzymes
which are integral membrane proteins with multiple
membrane spanning domains (Carman and Kelley, 1992;
Heacock et al., 1996; Saito et al., 1997; Volta et al., 1999;
Martin et al., 2000; Nigou and Besra, 2002). The TbCDS
protein contains the typical phosphatidate cytidyl-
transferase signature: S-x-[LIVMF]-K-R-x(4)-K-D-[GSA]-
x(2)-[LIF]-[PGS]-x-H-G-G-[LIVMF]-x-D-R-[LIVMFT]-D
(highlighted yellow in Fig. S1A), which is shared by almost
all predicted homologues, both eukaryotic and prokaryotic
(Koonin, 1996; Ponting and Kerr, 1996).
BLAST searches using typical prokaryotic CDS
sequences recovered a putative second CDS gene in
Trypanosoma cruzi (Tc00.1047053508707.140 /TcCLB
.508707.140), Trypanosoma vivax (TvY486_0025800)
and several Leishmania species (LinJ.32.3010,
LmjF.32.2870, LmxM.31.2870, LtaP32.3050) but not in
T. brucei.All of these genes are more similar to the prokary-
otic than the eukaryotic CDS genes. An alignment of these
predicted proteins with some typical prokaryotic CDS
sequences are shown in Fig. S3A with a corresponding
phylogenetic tree in Fig. S3B. This shows that the proto-
zoan homologous have N-terminal extensions as well as
several insertions, making these gene products signifi-
cantly larger than the average prokaryotic CDS (Agabian,
1990).
It is assumed that organisms that have multiple copies
of CDS, i.e. humans and Arabidopsis, target them to
different cellular locations, providing local concentrated
pools of CDP-DAG to be used by different phospholipid
pathways. This may also be true for T. cruzi and Leish-
mania that have both a eukaryotic and prokaryotic
version, but T. brucei have likely lost their prokaryotic
homologue in the recent past.
Rescue of yeast of CDS null
To confirm that the T. brucei CDS homologue encoded for
a functional CDS, it was used to rescue viability of an
otherwise inviable yeast cds1 null strain. A schematic of
the strategy used is shown in Fig. S4. Briefly, a diploid
yeast strain heterozygous for a cds1 gene knockout
(CDS1/cds1::KanMX) containing yeast CDS1 on the
URA3-marked pRS426-MET25 plasmid was used to gen-
erate haploid cds1 knockout strains that were comple-
mented by the plasmid. As yeast CDS1 is an essential
gene, loss of this plasmid resulted in lethality so these
strains could not grow in the presence of 5-fluoro-orotic
acid (5-FOA), which selects against the URA3 marker
on the plasmid (Fig. S5 – compare A and B). Using a
second, LEU2-marked plasmid (p405-TEF1), either
TbCDS or yeast CDS1 were introduced into this back-
ground. These strains, along with the parent strain and
transformants carrying the empty p405-TEF1 vector,
were tested for growth after counterselection for pRS426-
MET25-CDS1 on 5-FOA. Only the strains containing
either yeast CDS1 or TbCDS on the LEU2 selectable
plasmid were viable, while the parent strain with and
without the empty plasmid was non-viable (compare
Fig. 2A and B). Lipidomic analysis by electrospray mass
spectrometry of the yeast parent strain and the CDS1 null
expressing either the ectopic yeast CDS1 or TbCDS on a
plasmid showed alterations in their phospholipid profiles.
This may reflect a different acyl preference on the sub-
strate PA (Fig. S6A–C) resulting in slightly different CDP-
DAG species being formed and thus variation in the
relative ratio of the PI species formed (compare species
at 808 m/z and 836 m/z), which may impact on inosi-
tolphosphoceramide (IPC) formation and thus lipid
homeostasis in the resulting yeast strains (Carman and
Fischl, 1992). Collectively, this functional complementa-
tion provides definitive evidence that TbCDS encodes a
functional CDS enzyme as it is able to rescue an other-
wise non-viable yeast cds1 null mutant.
A B
Fig. 2. Plasmid shuffle shows TbCDS can complement the yeast
cds1::KanMX knockout.
A. After transformation of haploid cds1::KanMX [pRS425-MET25-
CDS1] with empty p405-TEF1, p405-TEF1-TbCDS or p405-TEF1-
CDS1 and selection for both plasmids, the three strains plus the
cds1::KanMX [pRS425-MET25-CDS1] parent strain were plated on
YPD, where all strains grew normally.
B. Strains were then plated onto YPD +5-FOA in order to select
against the pRS425-MET25-CDS1 plasmid. Parent = cds1::KanMX
[pRS425-MET25-CDS1]; Empty = Parent transformed with
p405-TEF1; Yeast = Parent transformed with p405-TEF1-CDS1;
TbCDS = parent transformed with p405-TEF1-TbCDS.
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Is CDS essential in bloodstream form T. brucei?
According to the TriTrypDB, the TbCDS (Tb427.07.220) is
expressed equally throughout the various life cycles
stages, and this was confirmed in strain 427 by RT-PCR
in both the bloodstream and procyclic forms (Fig. S7).
In addition, washed bloodstream T. brucei membranes
exhibited CDS activity, as they were able to catalyse the
conversion of [3H]CTP and PA into [3H]CDP-DAG product
(Fig. 1B).
To ascertain if TbCDS is an essential gene in T. brucei, a
conditional TbCDS knockout was created.As the ‘wild type’
cell line used here constitutively expresses the T7 RNA
polymerase and the tetracycline repressor protein, a tetra-
cycline inducible (Ti) haemagglutinin (HA)-tagged ectopic
copy of the TbCDS was introduced (pLew 100) into the cell
line prior to deletion of both TbCDS alleles in the presence
of tetracycline, allowing the creation of a conditional double
knockout (Wirtz et al., 1999). The resulting TbCDS-HATi
ΔTbCDS::PAC/ΔTbCDS::HYG clone was obtained and the
genotype of the cell-line confirmed by PCR (Fig. S8A),
while expression of the ectopic TbCDS copy was con-
firmed as being tetracycline inducible by anti-HA Western
blot (Fig. S8B). Please note, the apparent mobility of CDS
anti-HA band is significantly higher than the predicted
∼ 47 kDa, as is commonly seen for multiple transmem-
brane domain proteins on SDS-PAGE.
To establish whether CDS is an essential gene, the
growth of the TbCDS-HATi ΔTbCDS::PAC/ΔTbCDS::HYG
(TbCDS CKO) cell line was monitored in tetracycline-free
HMI-9 in the absence or presence of tetracycline (Fig. 3A
and B). In the absence of tetracycline a growth defect was
A
B
1          2          3
~70kDa
~100kDa
C
Loading
control~70kDa
~100kDa
An?-HA 
+ TET
- TET
+ TET
- TET
Fig. 3. Growth curves and Western blot of
the TbCDS conditional double knockout cell
line. Cells were washed with tetracycline-free
HMI-9, transferred to tetracycline-free media
and counted daily. Growth curves are shown
for wild type cells in this media.
A. Growth curves of T. brucei CKO in the
absence (black/−TET) or presence
(grey/+TET) of tetracycline (A) actual number
of cells per ml of culture × 104 after number of
hours cultured in the absence (black/−TET) or
presence (grey/+TET) of tetracycline.
B. Growth curves of log cumulative number of
cells over time in the presence and absence
of tetracycline. These growth curves were
done numerous times and were highly
reproducible.
C. Anti-HA western of T. brucei CKO either
after 48 h without tetracycline (lane 1), or with
tetracycline (lane 2), or 150 h without
tetracycline (lane 3). Reoccurrence of
HA-tagged TbCDS despite the absence of
tetracycline suggests regrowth is due to cells
reverting and breaking the tetracycline control
of TbCDS expression. Loading control is
ponceau stained Western blotted membrane.
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apparent after 24 h, and after 48 h cells started to die and
no visible TbCDS-HA protein was observed (Fig. 3C, lane
1). By 100 h the cell numbers were below the limits of
detection by light microscopy, however, some live cells
were visible after 120 h, following which growth resumed
as normal. The growth pattern observed was highly repro-
ducible. This revertant growth was likely due to a loss of
tetracycline control, as has previously been shown in
knockouts of essential genes (Chang et al., 2002; Martin
and Smith, 2006a), and was confirmed by anti-HA Western
blot showing production of the HA-tagged TbCDS in the
absence of tetracycline (Fig. 3C, lane 3).
Morphological phenotype of the CDS
conditional knockout
There were morphological changes in the TbCDS CKO cell
line after 42 h in the absence of tetracycline compared with
wild type cells (Fig. 4). In many of the trypanosomes there
was an apparent cell cycle arrest after replication of the
flagellum and the formation of a furrow. A pre-cytokinesis
stall is not uncommon in T. brucei mutants, but the stall
usually occurs before furrow formation (Hammarton et al.,
2007). DAPI staining revealed that in most cases these
cells had stalled at 1K2N, often with enlarged kinetoplast
and nuclei. This 1K2N phenotype is surprising given the
kinetoplast replicates prior to the nucleus and suggests a
defect in kinetoplastid segregation. This downstream affect
of depleted CDP-DAG levels suggests key structural
and/or signalling phospholipids may play an important part
in correct kinteoplastid DNA replication/segregation. This
could be at the tripartite attachment zone, where the basal
body is physically attached to the kinetoplast, passing
through both the cell and mitochondrial membranes.Avery
similar, but not identical phenotype was observed in the
knock-down of T. brucei MOB1, which caused a stall in
cytokinesis through an inhibitory effect on kinetoplast seg-
regation (Hammarton et al., 2005).
Biochemical phenotype of the TbCDS
conditional knockout
Total lipids were extracted from TbCDS CKO cells grown in
the absence (42 h) or presence of tetracycline and ana-
lysed by electrospray-mass spectrometry. As expected,
lipid extracts from TbCDS CKO grown in the presence of
tetracycline have a similar distribution of molecular species
to that of wild-type cells across the phospholipid classes,
PI, PA, PG, PS, PE, PC and sphingolipids to that of
wild-type cells (data not shown). Comparison of the posi-
tive ion mode survey scans of TbCDS CKO in the presence
and absence of tetracycline shows the relative proportion
of the PC and SM remain relatively unchanged (Fig. 5A
and B). Some notable differences were an increase in DAG
36:2–4 (615.5 m/z) and an increase in TAG C62:7–9
(987.6 m/z) (Fig. 5B). The negative ion mode survey scans
of TbCDS CKO in the presence and absence of tetracy-
cline show dominant ions at 727.1 and 774.1 m/z (Fig. 5C
and D) corresponding to the major plasminogen PE
(a-36:1) and PS (a-36:1) respectively. In the absence of
tetracycline two species at 686.1 and 700.0 m/z identified
by fragmentation as PA a-C18:0/C18:2 (Fig. S9A), and its
diacyl counterpart PA C18:0/C18:2 (Fig. S9B) are both
absent compared with cells grown the presence of tetra-
cycline. These reductions coincide with a significant
increase in several PG species including those at 760.0
and 825.9 m/z identified as including a-C18:0/C18:2 and
C18:0/C22:4 respectively (Fig. S9C and D).
Finally, the absence of tetracycline gives rise to a sig-
nificant decrease in the major PI species at 861 and
912 m/z in corresponding to C36:1 and C40:4 respec-
tively (Fig. 5C and D), with a disproportional reduction
between these major PI species. To investigate this
further, parent-ion scanning of m/z 241 (collision-induced
fragmentation, forming inositol-1,2-cyclic phosphate) in
negative ion mode which only shows the PI species
(Fig. 5E and F) allowed the relative ratio to be calculated,
showing a decrease from 1.29 to 0.38 (861 to 912 m/z).
Quantification of the total myo-inositol containing phos-
pholipids by GC-MS showed that in the absence of tetra-
cycline there was only 57 ± 6% myo-inositol contain-
ing lipids compared with cells grown in the presence of
tetracycline.
The decrease in CDS activity obviously causes a
marked reduction in PI levels, however the disproportional
reduction implies the C36:1 species turns over faster than
the C40:4 species. No significant disproportional reduc-
tion was observed in our previous work on either INO1
(Martin and Smith, 2006a) or PI synthase (Martin and
Smith, 2006b). This study may indicate that that the cel-
lular location of either the synthesis or downstream use
of the PI species may be different. Alternatively, it may
highlight an issue with availability of certain CDP-DAG
species under conditions of limiting CDS activity.
The biochemical phenotype of the TbCDS CKO cells
was also investigated by in vivo radiolabelling experi-
ments with [3H]myristate, [3H]glycerol and [3H]inositol after
the cells had been grown either in the presence or
absence of tetracycline for 42 h and compared with wild-
type cells. After labelling, lipids were extracted, desalted,
separated by high performance thin layer chromatogra-
phy (HPTLC), and detected by fluorography.
Labelling of the TbCDS CKO cells grown in the absence
of tetracycline with [3H]myristate (Fig. S10A) showed no
significant decrease to those grown in the presence of
tetracycline, although there was a slight increase in the
labelling of neutral lipids (diacylglycerol and triacylglyc-
erol), confirming the observed increase in the positive ion
CDP-DAG synthase in bloodstream T. brucei 457
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DIC DAPI
A
B
Fig. 4. Comparison of wild-type and TbCDS
CKO cell morphology. Projections of Z-series
images taken by light microscopy. Left panel
shows DIC and right panel shows DAPI
staining and. Cells were fixed with 4%
paraformaldehyde, allowed to adhere to
poly-lysine coated slides and mounted with
anti-fade GOLD reagent containing DAPI.
A. Wild-type cells harvested from mid log
culture and fixed in 4% paraformaldehyde.
B. TbCDS CKO cells harvested from culture
48 h after the removal of tetracycline.
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Fig. 5. Lipidomic analyses by
electrospray mass spectrometry.
A and B. Mass spectrometric
analyses: Positive ion survey of total
phospholipids from wild-type (A)
and TbCDS CKO in absence of
tetracycline for 42 h (B).
C–F. Negative ion survey of total
phospholipids from wild-type (C) and
TbCDS CKO cells in absence of
tetracycline for 42 h (D). Parent-ion
scanning of the collision induced
fragment at 241 m/z of wild-type
single marker cells (E) and TbCDS
CKO cells in absence of tetracycline
for 42 h (F). The data presented here
are representative scans from one
set of samples, but these analyses
were carried out on several different
samples along with their
corresponding controls.
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mode survey scan (Fig. 5B). This is also a clear indication
that at this point under permissive conditions the cells are
still metabolically active. The incorporation of [3H]glycerol
into different glycerolipids (Fig. S10B) was considerably
altered in the TbCDS CKO cells in the absence of tetracy-
cline. There is significantly less labelling of PE and PI in the
knockout, but PC seems unaffected, while PG seems to
have increased. Surprisingly, the incorporation of [3H]ino-
sitol into PI and PIP seems relatively unaffected in the
TbCDS CKO (Fig. S10C), despite the [3H]glycerol labelling
showing a decrease in newly formed PI. However, this
anomaly is likely due to head-group swapping with pre-
existing unlabelled PI by the PI synthase as observed
previously (Martin and Smith, 2006a).
To investigate the possible detrimental effects on GPI
anchor formation caused by limited amounts of CDP-DAG,
washed trypanosomal membranes formed from wild-type
and TbCDS CKO in the absence of tetracycline (42 h) were
used in a cell-free-system assay with GDP-[3H]Man in
the presence or absence of UDP-GlcNAc. As expected,
with wild-type membranes the presence of GDP-[3H]Man
allows dolichol-phosphate-[3H]Mannose (DPM) to be
formed (Fig. 6A, lane 3) (Smith et al., 1996). The subse-
quent addition of UDP-GlcNAc allows the formation of
[3H]mannosylated GPI intermediates Man1GlcN-PI (M1),
Man2GlcN-PI (M2), Man3GlcN-PI (M3), Man3GlcN-
(acyl)-PI (aM3) (Fig. 6A, lane 1). The TbCDS CKO mem-
branes in the presence of GDP-[3H]Man formed DPM
(Fig. 6A, lane 4). However, in the presence of UDP-
GlcNAc, there was no M1, M2 or aM3 bands with only a
very faint M3 band visible (Fig. 6A, lane 2), indicating a
significant reduction in flux through the GPI pathway.
In order to clarify that this lack of GPI biosynthetic flux
was due to a lack of newly synthesized PI from the ER
resident PI synthase (that utilizes CDP-DAG), a separate
assay with UDP-[3H]GlcNAc in the absence of GDP-Man
was conducted. As expected wild-type membranes
formed two strong bands corresponding to GlcNAc-PI and
GlcN-PI (Fig. 6B, lane 1), indicating ample endogenous PI
acceptor was available to catalyse the initial steps of the
GPI pathway. In contrast the TbCDS CKO membranes
showed significantly fainter bands for both GlcNAc-PI and
GlcN-PI (Fig. 6B, lane 2), suggesting a lack of endog-
enous PI in the ER membranes.
Collectively, these results clearly demonstrate the
reduced flux through the GPI biosynthetic pathway is
caused by a shortage of PI in the ER, due to depletion of
CDS activity.
Subcellular localization of TbCDS in bloodstream
form T. brucei
The observed differential effects on the two major PI
species caused by reduced TbCDS expression in BSF
T. brucei suggests two separate pools of CDP-DAG may
be synthesized by distinctly localized TbCDS enzymes.
To examine the subcellular localization of TbCDS, we
used the TbCDS CKO cell line, as the viability conferred
by the tetracycline induced copy of pLew 100 TbCDS-HA
confirms that the protein is correctly expressed and local-
ized. The TbCDS-HA protein was detected by Western
blot of total protein (Fig. 3C, lane 2). The cells were
stained against the HA-tagged CDS and for ER localized
BiP protein (Bangs et al., 1993; Fig. 7). The strongest
signal from HA-tagged TbCDS comes from the region
between the nucleus and kinetoplast, while punctuate
staining is visible throughout the cell. Since TbCDS is a
membrane protein this pattern of staining indicates that it
is localized to the membrane of subcellular organelles
rather than the plasma membrane. Intense staining
between the nucleus and kinetoplast is indicative of a
DPM
M1
aM3
M2
M3
1         2          3         4
1       2   
[3H]GlcNAc-PI
[3H]GlcN-PI
A
B
Fig. 6. TbCDS is essential for formation of GPI intermediates.
A. Cell free system of wild-type (lanes 1 and 3) and TbCDS CKO
cells in absence of tetracycline for 42 h (lanes 2 and 4),
membranes were incubated with GDP-[3H]Man in the presence
(lanes 1 and 2) and absence (lanes 3 and 4) of UDP-GlcNAc.
B. Cell free system of wild-type (lane 1) and TbCDS CKO cells in
absence of tetracycline for 42 h (lane 2) membranes incubated with
UDP-[3H]GlcNAc. O = origin, F = front. Solvent: 180:140:9:9:23
CHCl3 : MeOH : 30% NH3:1 M NH4Ac : H2O. Positions of the GPI
intermediates are shown on left hand side. The data presented
here are representative TLCs, of labellings done on several
biological replicates along with their corresponding controls.
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Golgi localization, which has previously been shown to be
the location of the downstream enzyme, PIS (Martin and
Smith, 2006a) and is consistent with a requirement of
CDP-DAG for the synthesis of the bulk of PI in the cell.
The perinuclear staining, and the staining throughout the
cell indicate ER localization, where TbCDS could supply
CDP-DAG required for the ER localized PIS to make PI
for GPI anchors.
Some co-staining of TbCDS with the ER protein BiP
does occur, particularly between the nucleus and the kine-
toplast, although co-staining is not complete and some
punctuate staining of TbCDS appears to occur outwith the
1. DIC 2. DAPI 3. FITC 4. TRITC 5. MERGED
Fig. 7. Localization of CDS-HA in bloodstream T. brucei. T. brucei cells expressing CDS-HA were co-stained for the nuclear marker DAPI,
the HA epitope and the ER marker BiP. 1. DIC image, 2. DAPI staining. 3. HA-epitope staining and FITC detection. 4. BiP staining and TRITC
detection. 5. Merged image.
462 A. C. Lilley et al. ■
© 2014 The Authors. Molecular Microbiology published by John Wiley & Sons Ltd., Molecular Microbiology, 92, 453–470
ER. Even within the ER, TbCDS is not evenly distributed
and it may be present in specific areas of the ER (i.e.
between the nucleus and the kinetoplast), possibly the
mitochondrial associated membranes.
Discussion
This study has given us new insight into the glycerophos-
pholipid biosynthesis in bloodstream form T. brucei.
Figure 8 presents a model of glycerophospholipid synthe-
sis revised to include the alternative mechanisms indi-
cated by our results.
CDP-DAG synthase and PI synthase proteins are each
encoded by single genes but CDP-DAG and PI are syn-
thesized as separate pools in the Golgi and the ER, pos-
sibly for different functions (Martin and Smith, 2006b).
A myo-inositol transporter takes cytosolic inositol into
the lumen of the Golgi where it is utilized to make PI via
the Golgi resident PI synthase, whose active site faces
the lumen of the Golgi (Gonzalez-Salgado et al., 2012).
The Golgi resident CDS may provide the CDP-DAG for
this PI synthase; however, the CDP-DAG must be made
on the cytosolic face of the Golgi as it uses cytosolic CTP,
and therefore CDP-DAG must be translocated across the
membrane into the lumen of the Golgi.
The PI made in the Golgi is the source of bulk cellular
PI, and is not used for GPI anchor synthesis, but is prob-
ably used for PIP formation by the resident PI-4-kinase
required for post-Golgi sorting (Martin and Smith, 2006b).
Inositol-3-phosphate formed from glucose 6-phosphate
by the cytosolic INO1 is taken in to the ER by an unknown
transporter/mechanism, where it is dephosphorylated
by inositol monophosphatase activity (Eisenberg and Par-
thasrathy, 1987; Martin and Smith, 2006a). This de novo
synthesized inositol, presumably along with CDP-DAG
synthesized by a second pool of TbCDS in the ER is used
by the pool of ER resident PI synthase (Martin and Smith,
2006b) In the ER, as in the Golgi, the CDP-DAG must be
translocated to the inner leaflet. The resulting PI is sub-
sequently used for essential GPI biosynthesis (Martin and
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Fig. 8. Model of revised pathways for glycerophospholipid synthesis in bloodstream form T. brucei. Enzymes for which candidate genes have
been identified are indicated. Block arrows indicate transporters. MAM = mitochondrial associated membranes. Metabolite abbreviations:
Glc-6-P = glucose 6-phosphate; PA – phosphatidic acid; CDP-DAG – cytidine diphosphate diacylglycerol; PGP –
phosphatidylglycerophosphate; PG – phosphatidylglycerol, CL – cardiolipin, PS – phosphatidylserine, PE – phosphatidylethanolamine;
PI – phosphatidylinositol; PIPs – phosphorylated derivatives of phosphatidyl inositol; DAG – diacylglycerol; PE – phosphatidylethanolamine;
IPC – inositol phosphorylceramide. Enzyme abbreviations: CDS – cytidine diphosphate diacylglycerol synthase, PGPS –
phosphatidylglycerolphosphate synthase, CLS – cardiolipin synthase, PIS phosphatidlyinositol synthase, PIK – phosphatidylinositol kinase,
PSS – phosphatidylserine synthase, PSD – phosphatidylserine decarboxylase, PAP – phosphatidic acid phosphatase, DAGK – DAG kinase.
Dotted lines indicate putative pathways.
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Smith, 2006a). The high flux through the PI to GPI
pathway is likely be on a par with or higher than that of the
PI synthesized in the Golgi, meaning that the dynamic
pool of PI in the ER is very small as it is rapidly used. The
ER synthesized PI is likely also used for the production of
PIPs, which may occur in a subcompartment of the ER;
recently described in humans (Kim et al., 2011).
A cell cycle stall caused by the knockout of TbCDS
could indicate that PIP signalling has a role in cell cycle
regulation/control in bloodstream form T. brucei. Addition-
ally, depletion of GPI anchor biosynthesis as observed in
this study has previously been shown to cause a cell cycle
stall due to the cells being unwilling to dilute their GPI
anchored VSG on the cell surface (Smith et al., 2009).
Previous work has indicated that the synthesis of PS via
CDP-DAG does not occur in T. brucei (Signorell et al.,
2008) and in support of this, the T. brucei PSS enzyme
shows sequence similarity to the mammalian PSS2
which utilizes PE in a head-group exchange mechanism,
rather than the yeast or prokaryotic PSS proteins which
are CDP-alcohol phosphatidyltransferases (Nikawa et al.,
1987; Johnson et al., 1997). However, since knockdown
of de novo synthesis of PE via the Kennedy pathway did
not affect the amount of PS in bloodstream form T. brucei
(Gibellini et al., 2009), it is possible that the T. brucei PSS
is also capable of utilizing PC as a substrate. The produc-
tion of PE through PS decarboxylation occurs in prokary-
otes, yeast, and to a limited extent in mammals (reviewed
in Schuiki and Daum, 2009), but this activity does not
occur in bloodstream form T. brucei, even under condi-
tions of depleted PE levels (Gibellini et al., 2009). Surpris-
ingly, the T. brucei does encode a functional PS
decarboxylase as demonstrated by recombinant assays
and preliminary work indicates that it is essential in blood-
stream form (T.K. Smith, unpublished).
For the first time, evidence is presented here that in
T. brucei PG must be synthesized via an alternative
mechanism neither directly or indirectly involving CDP-
DAG as a lipid donor. The phosphatidylglycerol-phosphate
synthase (PGPS) in procyclic T. brucei has been shown to
be responsible for PG production, and its downregulation
causes a growth defect (Serricchio and Buetikofer, 2013).
However, the enzyme’s substrate preference has not
been experimentally confirmed. Given the increase in PG
species seen in this study under limiting CDS activity it
seems unlikely that CDP-DAG is the sole substrate for
PGPS. Many enzymes of the phospholipase-D like super-
family, which includes PGPS, indicate a lack of substrate
specificity (Shibuya et al., 1985; Nishijima et al., 1988;
Chang et al., 1998; Tan et al., 2012). It is therefore possible
that PGPS may be able to utilize an alternative to CDP-
DAG, for example PS as the lipid donor to produce PG. PS
synthesis from PE is thought to occur in the mitochondrial
associated membrane of the ER (Vance, 1990; Shiao and
Vance, 1995; Stone and Vance, 2000) and so it would be
ideally localized to feed into the mitochondrial phospholipid
pathway where both T. brucei PGPS and CLS are found
(Serricchio and Buetikofer, 2012; 2013).
The non-reliance upon CDG-DAG by this branch of lipid
metabolism may be a strategy by the parasites to limit
CTP use, as the CTP level is already dangerously low in
bloodstream form T. brucei.
The T. brucei cellular response to glycerophospholipid
disruption results in excess PA or DAG, which is fed into
the Kennedy Pathway and converted to PG via PS, pos-
sibly in order to maintain a balance of cellular lipid as PG
is considered a relatively harmless lipid to produce in
excess. Whether PS is the major source of PG and CL
under normal circumstances or whether synthesis of PGP
from CDP-DAG normally produces the bulk of PG remains
to be determined. In many organisms CDS is localized to
the mitochondria, and there is a chance that this is also
the case in bloodstream form T. brucei, although further
colocalization experiments and subcellular fractionation
would be required to confirm this.
In summary this study indicates that the CDP-DAG
synthesized is primarily utilized by PI synthases in both
the ER and Golgi. This new knowledge may lead to the
discovery and validation of other novel drug targets
against African sleeping sickness.
Experimental procedures
Cloning of the T. brucei TbCDS gene
A putative CDS gene was identified in the T. brucei genome
database (Sanger Centre) using BlastP search with the S. cer-
evisiae CDS1 genomic sequence as the query. The open
reading frame was amplified from T. brucei genomic DNA
using the forward and reverse primers 5′-GAGAAGCTTATG
AAAACAAGTCCAGCAAG-3′ and 5′-TGCTTAATTAACTTT
TCTGTGAGAGACCTATTAAG-3′ containing HindIII and PacI
restriction sites respectively (underlined). A band of the
expected size of c. 1.2 kb was amplified using KOD polymer-
ase, purified using a QIAquick PCR purification kit (Qiagen)
and cloned into pCR-Blunt II TOPO (Invitrogen).
Bioinformatics
Phylogenetic analysis was performed using Mobyle@
Pasteur platform from the Institut Pasteur ‘Projets et Dével-
oppements en Bioinformatique’ Team and the Ressource
Parisienne en Bioinformatique Structurale (http://mobyle
.pasteur.fr). Sequences were aligned using Clustal O 1.0.2:
Multiple Alignment (Sievers et al., 2011). Alignments were
manually checked and gap regions and ambiguously aligned
regions were excluded from further analysis. Phylogeny was
inferred using the protein sequence parsimony method from
the PHYLIP package (Phlipi 3.67 ProtPars) (Felsenstein,
1989).
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Saccharomyces cerevisae culture
The Saccharomyces cerevisiae strain heterozygous for the
cds1::KanMX knockout was created by the Saccharomyces
Genome Deletion Project (Winzeler et al., 1999) and
obtained from Euroscarf collection. Basic yeast methods,
growth media, and routine recombinant DNA methodology
were performed as previously described (Gietz et al., 1992;
Amberg et al., 2005). For general growth and maintenance of
cultures Saccharomyces cerevesiae was either grown on
liquid YPD containing 1% bacto-yeast extract, 2% bacto-
peptone and 2% dextrose, or YPD plates containing 2%
bacto-agar. Otherwise, auxotrophs were grown on complete
minimal glucose medium (SC) containing 0.67% bacto-yeast
nitrogen base without amino acids (Sigma) and 2% dextrose.
This was supplemented with appropriate amino acid mix to
select for plasmids with auxotrophic markers. Initially the
amino acids were made up as sterile stocks and added as
required, but later the appropriate amino acid mixes were
bought from Sigma-Aldrich. Yeast cultures were grown at
30°C, with constant shaking when in liquid media.
Construction of TbCDS and CDS1 pRS426-MET25 and
p405-TEF1
TbCDS was isolated from T. brucei strain 427 genomic DNA
using the forward and reverse primers 5′-GAGGGATCCGATG
AAAAACAAGTCCAGCAAG-3′ and 5′-CGGCTCGAGCCTA
TTCTGTGAGAGACCTATTAAGAGTCGAG-3′ containing the
HindIII and XhoI restriction sites respectively. Yeast CDS1 was
isolated by colony PCR from S. cerevisiae using the forward
and reverse primers 5′-CCCAAGCTTATGTCTTGACAACC
CTGGAGATGAA-3′ and 5′-CGGCTCGAGTTCAAGAGTGA
TTGGTCAATGATTTCTTGGTCAC-3′ containing the HindIII
and XhoI restriction sites respectively (underlined). Bands of
the expected size of c. 1.2 kb (TbCDS) or 1.4 kb (yeast CDS1)
were amplified using KOD polymerase, purified using a
QIAquick PCR purification kit (Qiagen) and cloned into the
yeast expression vector pRS426 MET25 (2μ URA3) or p405-
TEF1 [gift from Nicholas Buchler (Addgene plasmid #15968)]
using the HindIII and XhoI restriction sites.
Complementation of cds1::KanMX with TbCDS and
yeast CDS1 by tetrad analysis and plasmid shuffling
The diploid S. cerevisiae cds1::KanMX heterozygous strain
was transformed with pRS426-MET25 containing either yeast
CDS1, T. brucei CDS, or with the empty vector, selecting
transformants on SCD–Ura medium. These transformants,
together with the original heterozygous CDS1/cds1::KanMX
null strain were sporulated and tetrads dissected in the
absence of methionine in order to allow expression of the
CDS gene on the pRS426-MET25 plasmid. While haploid
cds1::KanMX segregants containing yeast CDS1on pRS426-
MET25 could be readily isolated, this was not the case with
pRS426-MET25 carrying T. brucei CDS. In case this reflected
poor expression from the MET25promoter on pRS426-
MET25, the haploid cds1::KanMX knockouts containing
yeast CDS1 on pRS416 MET25 (MET15 his3 leu2 ura3
cds1::KanMX [pRS425-MET25-CDS1]) were used to carry out
a ‘plasmid shuffle’ with TbCDS or yeast CDS1 expressed
instead from p405-TEF1, which carries the strong TEF1 pro-
moter. The yeast cds1::KanMX [pRS425-MET25-CDS1] was
transformed with p405-TEF1-TbCDS, p405-TEF1-CDS1 or
empty p405-TEF1, selecting for both plasmids on SC–Leu–
Met–Ura. Cells were then cultured on SC–Leu–Met (i.e. + Ura)
followed by plating on SC–Leu + 5-fluoro-orotic acid (5-FOA)
to select against the URA3 containing pRS426-MET25-CDS1,
thereby testing for complementation of cds1::KanMX by the
p405-TEF1-based plasmids.
Construction of TbCDS pLew vectors
The TbCDS1 ORF was excised from Topo using HindIII and
PacI and subsequently ligated into the tetracycline inducible
expression vectors pLew82 and pLew100 (Wirtz et al., 1999)
via the HindIII and PacI restriction sites.
Construction of T. brucei gene replacement cassettes
The 5′ and 3′ UTRs immediately adjacent to the TbCDS open
reading frame were amplified from T. brucei genomic DNA
using KOD polymerase. The primers 5′-ATAAGTAAGCGGC
CGCTGATTAACGCACCC-3′ and 5′-CGTTTAAACTTACG
GACCGTCAAGCTTCTAGACGCTTTCACTGAAAAATGC-3′
were used for the 5′ untranslated region (UTR), amplifying
the expected 516 bp product and primers 5′-TGACGGTCC
GTAAGTTTAAACGGATCCTCCATGTTGGAAGGGCACG-3′
and 5′-AGTAAGCGGCCGCCCTTGAAAACAATGGTGTAT
AC-3′ resulted in the correct 179 bp 3′ UTR product.
These amplified products were used in a knitting PCR,
resulting in a 695 bp product in which the 5′ UTR was joined
to the 3′ UTR via a short BamHI–HindIII linker region con-
tained within the described primers (italics) and a NotI site
(underlined) at each end. This PCR product was ligated into
pGEM-5Zf(+) (Promega) using NotI sites, and the hygromy-
cin (HYG) or puromycin (PAC) resistance genes were ligated
between the BamHI and HindIII restriction sites. Plasmid
DNA was prepared using a QIAprep Miniprep Plasmid Kit
(Qiagen). After digestion with NotI the DNA was precipitated
with sodium acetate/ethanol and dissolved in sterile water to
a final concentration of 1 μg μl−1.
Cultivation and genetic modification of T. brucei
Bloodstream form T. brucei strain 427, which had been pre-
viously modified to express both T7 polymerase and the
tetracycline repressor protein (Wirtz et al., 1999), are referred
to here as wild-type cells for convenience. Cells were grown
HMI-9 media supplemented with G418 (2.5 μg ml−1) at 37°C
with 5% CO2 as described elsewhere (Wirtz et al., 1999;
Chang et al., 2002; Roper et al., 2002). Transformation con-
ditions and subsequent drug selection were also described
elsewhere (Wirtz et al., 1999; Chang et al., 2002; Roper
et al., 2002).
After drug selection with phleomycin, several TbCDS-HATi
clones were obtained and integration of the pLew100 ectopic
copy was confirmed by PCR using primers specific to the
pLew100 vector (data not shown). The first TbCDS allele was
deleted from the TbCDS-HATi cell line using a PAC knockout
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cassette. TbCDS-HATi ΔTbCDS::PAC clones were obtained
by selection with puromycin. The second TbCDS allele was
replaced with the hygromycin resistance gene.
For experiments requiring tetracycline-free conditions, Tet-
system approved fetal calf serum (Clonetech) was used.
When required, tetracycline was added to the media at a final
concentration of 1 μg ml−1. For tetracycline-free experiments,
cells were washed three times in tetracycline-free HMI-9 and
resuspended in tetracycline-free media at 5 × 104 cells ml−1.
Cells were counted each day and were passaged only when
the density was between 2 and 3 × 106 cells ml−1 (normally
every second day).
PCR confirmation of TbCDS knockout
The genotype of the conditional mutant was verified by PCR
analysis using primer combinations to amplify sections of the
knockout construct and primer combinations to amplify the
TbCDS in its genomic context. If both genomic copies of the
gene had indeed been deleted, there should be no product
with the latter. The following forward primers were used:
5′-AAGCTTATGACCGAGTACAAGCCCACGGTGCGCC-3′,
5′-AAGCTTATGAAAAAGCCTGAACTCACCGCGAC-3′ or 5′-
GAGAAGCTTATGAAAACAAGTCCAGCAAG-3′ along with
the reverse primer 5′-AGTAAGCGGCCGCCCTTGAAAACA
ATGGTGTATAC-3′.
RT-PCR
To confirm TbCDS transcription, RT-PCR was performed
using the 5′-ATAAGTAAGCGGCCGCTGATTAACGCACCC-
3′ and CDS pLew R primers to amplify the TbCDS ORF.
Reverse transcription PCR was performed using the Super-
Script™ One-Step RT-PCR kit with Platinum® Taq (Invitro-
gen) following the manufacturers recommendation. Reaction
components were 2× Reaction Mix, 10 pg–1 μg template
RNA, 10 μM sense primer, 10 μM anti-sense primer, 1 μl
0.2 μM RT/Platinum® Taq Mix, DEPC treated water to 50 μl.
CDS enzyme assays
The assay used for TbCDS activity was based on those
described by Sparrow and Raetz (1985) and Wu et al. (1995).
Washed T. brucei cells were harvested by centrifugation,
washed twice in trypanosome dilution buffer (TDB, 5 mM
KCl, 80 mM NaCl, 1 mM MgSO4, 20 mM NaH2PO4, 2 mM
NaH2PO4, 20 mM glucose, pH 7.7) and lysed with 800 μl ice
cold water. Two hundred microlitres of 5× incorporation buffer
(250 mM Tris-maleate pH 6.5; 15 mM MgCl2; 5 mg ml−1 BSA,
1.25 mM DTT) was added to the lysed cells, followed by
centrifugation at 1000 rpm to remove whole cells. The cell
membrane pellet was washed twice in incorporation buffer and
the cell pellet resuspended in 85 μl incorporation buffer fol-
lowed by sonication. Resuspended membranes were added
to reaction tubes to make a final assay volume of 100 μl. The
standard assay reaction consisted of washed crude mem-
brane extract in 50 mM Tris-maleate pH 6.5; 3 mM MgCl2;
1 mg ml−1 BSA; 0.25 mM DTT; 1 mM [3H]CTP at 9 μCi mM−1;
1.5 mM phosphatidic acid, 15 mM TX-100 in a total volume of
150 μL. The assay was incubated at 30°C for 20 min, and
stopped by addition of 666 μl 1:1 (v/v) CHCl3:MeOH. Radiola-
belled glycolipids were extracted into the resulting 10:10:3
CHCl3 : MeOH : H2O (v/v) by shaking at 4°C for at least 1 h.
Assay mixtures were spun at full speed and the supernatant
evaporated to dryness. Two hundred microlitres of CHCl3 and
200 μl of 0.1 M HCl were then added to the tubes which were
vortexed and briefly spun. The chloroform layer was removed
and washed twice with 0.1 M HCl followed by evaporation to
dryness. The resultant radiolabelled glycolipids were analysed
by silica 60-HPTLC in solvent system 25:15:4:2 (v/v)
CHCl3 : MeOH : CH3COOH : H2O. Dried HPTLC plates were
sprayed with En3hanceTM Spray and radiolabelled glycolipids
visualized by fluorography.
In vivo T. brucei metabolic labelling
For each metabolic labelling, 1–2 × 107 mid-log cells were
centrifuged (800 g, 10 min), washed in glucose free minimal
essential media, before being resuspended in the same
media at a final concentration of 1 × 107 cells ml−1. Cells were
labelled for 1 h at 37°C with 50 μCi ml−1 of either [9,10-3H(N)]-
Tetradecanoic acid (myristic acid) (47 Ci mmol−1) (Perkin
Elmer); [2-3H]-inositol (20 Ci mmol−1) or [1,2,3-[3H]]-glycerol
(20 Ci mmol−1) (both American Radiolabelled Chemicals) in a
shaking water bath. The cells were collected by centrifugation
(800 g for 10 min) and samples taken for analysis. Lipids
were extracted using chloroform : methanol : water (10:10:3
v/v) for 1 h, the supernatant removed and the pellet re-
extracted with chloroform : methanol (2:1 v/v) for 1 h. The
supernatants were pooled and dried before samples were
desalted using butanol/water partitioning. Lipids were
separated by HPTLC using silica 60 HPTLC plates and chlo-
roform : methanol : water (10:10:3 v/v) as the solvent. Radi-
olabelled lipids were detected by fluorography at −80°C, after
spraying with En3hanceTM and using Kodak XAR-5 film with
an intensifying screen.
Lipidomic analysis
Lipids were extracted from T. brucei as described previously
(Richmond et al., 2010). Briefly, mid-log cells are collected by
centrifugation (800 g, 10 min) washed with PBS and sus-
pended in 100 μl PBS and transferred to a glass tube. A total
of 375 μl of 1:2 (v/v) CHCl3:MeOH added and vortexed. The
sample is agitated vigorously for a further 10–15 min. The
sample is now made biphasic by the addition of 125 μl of
CHCl3, vortex and then 125 μl of H2O and vortexed again and
centrifuged at 1000 g at RT for 5 min. The lower chloroform
phase is transferred to a new glass vial, dried under nitrogen
and stored in the fridge.
Total lipid extracts were dissolved in 15 μl of choloroform :
methanol (1:2) and 15 μl of acetonitrile : isopropanol : water
(6:7:2) and analysed with a Absceix 4000 QTrap – a triple
quadrupole mass spectrometer equipped with a nanoelectro-
spray source.
Samples were delivered using either thin-wall nanoflow
capillary tips or a Nanomate interface in direct infusion mode
(∼ 125 nl min−1). The lipid extracts were analysed in both
positive and negative ion modes using a capillary voltage of
1.25 kV. MS/MS scanning (daughter, precursor and neutral
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loss scans) were performed using nitrogen as the collision
gas with collision energies between 35–90 V. Each spectrum
encompasses at least 50 repetitive scans.
Tandem mass spectra (MS/MS) were obtained with colli-
sion energies as follows: 35–45 V, PC in positive ion mode,
parent-ion scanning of m/z 184; 35–55 V, PI in negative ion
mode, parent-ion scanning of m/z 241; 35–65 V, PE in nega-
tive ion mode, parent-ion scanning of m/z 196; 20–35 V, PS in
negative ion mode, neutral loss scanning of m/z 87; and
40–90 V, for all glycerophospholipids (including PA, PG and
CL) detected by precursor scanning for m/z 153 in negative
ion mode. MS/MS fragmentation/daughter ion scanning was
performed with collision energies between 35–90 V. Assign-
ment of phospholipid species is based upon a combination of
survey, daughter, precursor and neutral loss scans, as well as
previous assignments (Richmond et al., 2010). The identity of
phospholipid peaks was verified using the LIPID MAPS:
Nature Lipidomics Gateway (http://www.lipidmaps.org). In
order to compare the peak heights relative to each other,
peaks were measured by ion intensities and their relative
ratios were calculated.
Cell-free system assay of GPI biosynthesis
Membranes of T. brucei wild-type and TbCDS conditional null
mutants grown in the presence or absence of tetracycline for
30, 36 and 42 h were isolated and prepared as described
previously (without the addition of tunicamycin prior to lysis)
(Masterson et al., 1989), snap frozen in liquid nitrogen and
stored at −80°C until required. A total of 1 × 107 cell equiva-
lents were used per assay: Briefly, membranes were washed
twice in 10 ml of wash buffer (50 mM NaHEPES, pH 7.4,
250 mM KCl, 5 mM MgCl2, 100 μM tosyl-L-lysine chlorome-
thyl ketone and 1 μg ml−1 leupeptin). The membranes were
then resuspended by sonication in 2× incorporation buffer
(2 times concentrated wash buffer containing 10 mM MnCl2,
1 μg ml−1 of tunicamycin and 1 mM DTT) and added to
a reaction tube containing an equal volume of GDP-
[3H]Mannose (0.3 μCi per 107 cell equivalents), with and
without 1 mM UDP-GlcNAc, or just [3H] UDP-GlcNAc (1.0 μCi
per 107 cell equivalents). The cell-free system was then soni-
cated briefly, incubated at 30°C for 1 h and the reaction
stopped by the addition of 267 μl of chloroform: methanol
(1:1 v/v). Radiolabelled glycolipid products were recovered
by extraction into a chloroform/methanol/water mixture
(10:10:3), evaporated to dryness, partitioned between butan-
1-ol and water (Smith et al., 1996), and analysed by HPTLC
in solvent system 180:140:9:9:23 (chloroform: methanol: 1 M
ammonium acetate: concentrated ammonia: water). Dried
HPTLC plates were sprayed with En3HanceTM (Perkin Elmer),
and radiolabelled components were visualized by fluorogra-
phy at −80°C using Kodak Biomax MS films with an intensi-
fying screen.
Inositol analysis
Mid-log cells were collected by centrifugation (800 g, 10 min)
washed with TDB and stored at −20°C. Lipids were extracted
from these samples by the addition of 500 μl of chloroform
methanol mixture (2:1 v/v) and incubated at room tempera-
ture for 1 h. The supernatant was removed and the pellet
re-extracted with chloroform : methanol : water mixture
(1:2:0.8 v/v). Pooled supernatants were dried under nitrogen
prior to desalting by biphasic partitioning using 2:1
butanol : water (v/v). An internal standard of D6 myo-inositol
was added to samples prior to hydrolysis by strong acid (6 M
HCl, 110°C), derivitization with TMS and analysis by GC-MS,
according to the method of Ferguson (Ferguson, 1993). myo-
Inositol was quantified and the mean of three separate analy-
ses were determined.
Immunofluorescence
At least 1 × 106 cells were harvested from culture by centrifu-
gation at 800 g for 10 min at room temperature and washed
with TDB. Cells were fixed in PBS plus 4% paraformaldehyde
and processed on slides as described previously (Martin and
Smith, 2006a). Anti-BiP was a kind gift from Jay Bangs,
Buffalo. After the final washes in PBS the slides were
mounted in SlowFade® Gold Antifade Reagent with DAPI
(Invitrogen) and a coverslip was placed over the slide. Slides
were allowed to cure for 24 h at room temperature before
sealing the sides with nail varnish.
All immunofluoresence microscopy was performed on a
DeltaVision microscope (Applied Precision Inc.) and pro-
cessed using ImageJ software (Rasband, 1997–2012).
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